Free Trial
OTCMKTS:VYCO

Vycor Medical (VYCO) Stock Price, News & Analysis

$0.09
0.00 (0.00%)
(As of 07/22/2024 ET)
Today's Range
$0.09
$0.09
50-Day Range
$0.08
$0.13
52-Week Range
$0.03
$0.13
Volume
N/A
Average Volume
12,203 shs
Market Capitalization
$2.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
VYCO stock logo

About Vycor Medical Stock (OTCMKTS:VYCO)

Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement which grants for the license to provide NovaVision's products and therapies to patients and professionals in Germany, Austria and Switzerland. It primarily serves hospitals and medical professionals. Vycor Medical, Inc. was founded in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited.

VYCO Stock Price History

VYCO Stock News Headlines

Vycor Medical, Inc. (VYCO)
Medical Review Board
Collapse of the Petrodollar
The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.
Vycor Medical Inc
Vycor Medical Inc (VYCO)
See More Headlines
Receive VYCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vycor Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/17/2020
Today
7/22/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
OTCMKTS:VYCO
Previous Symbol
OTCMKTS:VYCO
CUSIP
92921M203
Employees
8
Year Founded
N/A

Profitability

Net Income
$-70,000.00
Pretax Margin
-7.04%

Debt

Sales & Book Value

Annual Sales
$1.46 million
Book Value
($0.10) per share

Miscellaneous

Free Float
30,335,000
Market Cap
$2.87 million
Optionable
Not Optionable
Beta
0.54
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Peter C. Zachariou (Age 62)
    CEO & Director
  • Mr. David Marc Cantor (Age 58)
    President & Director
  • Mr. Adrian Christopher Liddell (Age 65)
    Chairman & CFO

VYCO Stock Analysis - Frequently Asked Questions

How have VYCO shares performed this year?

Vycor Medical's stock was trading at $0.0772 at the beginning of 2024. Since then, VYCO shares have increased by 14.0% and is now trading at $0.0880.
View the best growth stocks for 2024 here
.

How were Vycor Medical's earnings last quarter?

Vycor Medical, Inc. (OTCMKTS:VYCO) issued its quarterly earnings data on Monday, August, 17th. The medical device company reported ($0.01) earnings per share (EPS) for the quarter. The medical device company earned $0.24 million during the quarter.

How do I buy shares of Vycor Medical?

Shares of VYCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Vycor Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Vycor Medical investors own include Fly Leasing (FLY), Idera Pharmaceuticals (IDRA), ACADIA Pharmaceuticals (ACAD), Bellicum Pharmaceuticals (BLCM), Drone Aviation (DRNE).

This page (OTCMKTS:VYCO) was last updated on 7/22/2024 by MarketBeat.com Staff

From Our Partners